Fetalix featured in Europe Day initiative highlighting the impact of EU funding
European funding programmes play a vital role in strengthening research, fostering innovation, and supporting the translation of scientific discoveries into technologies that benefit society. For many deep-tech startups, these initiatives provide the resources needed to bridge the gap between academic research and real-world application.
Fetalix featured in Revista Sábado on emerging approaches to pain treatment
Advances in regenerative medicine are opening new possibilities for the treatment of chronic conditions that have traditionally relied on symptom management. As innovative therapeutic strategies continue to emerge, communicating their potential to the wider public is essential.
Fetalix Secures Patent for Its Fetal-Inspired Regenerative Biomaterial
Fetalix has been granted a patent protecting its regenerative biomaterial technology for the treatment of intervertebral disc degeneration and associated low back pain. The patent represents an important milestone in the company’s development, securing intellectual property rights for key aspects of its product and supporting its continued advancement toward clinical application.
